Aegerion Pharmaceuticals, Inc. (AEGR)
-NasdaqGS 60.09 
0.87(1.43%) May 24, 4:00PM EDT|After Hours
:
60.96 0.87 (1.45%) May 24, 5:00PM EDT
| Prev Close: | 60.96 |
|---|
| Open: | 60.22 |
|---|
| Bid: | 59.15 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 62.00 |
|---|
| Beta: | 0.68 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 59.09 - 61.33 |
|---|
| 52wk Range: | 12.87 - 63.72 |
|---|
| Volume: | 278,464 |
|---|
| Avg Vol (3m): | 635,061 |
|---|
| Market Cap: | 1.73B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming ConferencesGlobeNewswire(Fri, May 24)
- [video] Options Activity Ahead of Pandora Earningsat CNBC(Thu, May 23)
- [video] Nasdaq Check: Tech Stocks Recoverat CNBC(Thu, May 23)
- Aegerion's Pricing Power Sends Shares Flyingat Seeking Alpha(Wed, May 22)
- Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocksat Seeking Alpha(Tue, May 21)
- Too Many Questions Make This Thursday Mover a Sellat Motley Fool(Mon, May 20)
- The Best- And Worst- Performing Biotech Stocks, May 10 To May 17at Forbes(Sun, May 19)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat, May 18)
- 4 Companies With Extreme Price Charts And High Statistical Probability Of Declineat Seeking Alpha(Fri, May 17)
- AEGERION PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Aegerion Stock Falls On Unusually High Volume (AEGR)at TheStreet(Fri, May 17)
- Presentation Pandemonium Equals 30% Popat Motley Fool(Fri, May 17)
- Aegerion price target raised to $65 from $50 at Leerinktheflyonthewall.com(Fri, May 17)
- Thursday’s movers: Berkshire hit by S&P downgradeat MarketWatch(Thu, May 16)
- Aegerion surges after bullish projection on Juxtapid potentialat theflyonthewall.com(Thu, May 16)
Key Statistics
| Forward P/E (1 yr): | 240.36 |
|---|
| P/S (ttm): | 1,427.14 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -2.28 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.63 |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | 0.41 |
|---|
Business Summary
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutics to treat debilitating and fatal rare diseases in the United States.
View More